Cancer drug trial halted over stability concerns; Philippines officials score fakes bust;

> Helix BioPharma's experimental cancer treatment was placed on clinical hold by the FDA, based on product stability concerns. Story

> The National Bureau of Investigation of the Philippines has made one arrest and seized about a half-million dollars' worth of fake medicines imported from India, Pakistan and Singapore. Article

Special Report:Top 10 Pharma CEO salaries of 2009. Report

> Hebei Aoxing API Pharmaceutical Company, a joint venture of Aoxing Pharma and Macfarlan Smith, has received a manufacturing licence from the China State Food and Drug Administration. Aoxing release

> A "tantalizing glimpse" of pharma company earnings is available from the spending breakdown of the U.K.'s Department of Health. Story

> India is considering whether to grant autonomous status to its three public-sector vaccine production units. Item

Special Report: Top 5 Game-Changing Drug Delivery Technologies. Report

> VR Laboratories, a start-up natural pharmaceutical company, is considering a site in Fort Myers, FL, for its headquarters. Article

> Hospira has named Frans Dubois to the new position of senior VP for Quality. Hospira release

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.